Cartilage Structure, Mechanical Loading, and the Pathophysiology of Osteoarthritis: A Physiotherapy Perspective

Articular cartilage is a highly specialized, avascular, and aneural connective tissue that covers the ends of bones within synovial joints, composed primarily of water (65-80%), type II collagen (10-20%), and large aggregating proteoglycans (10-15%) by wet weight ¹. The progressive degradation of this tissue is the defining feature of osteoarthritis (OA), a condition that represents a major global health challenge. According to a comprehensive analysis of the 2021 Global Burden of Disease Study, the global prevalence of knee osteoarthritis was 374.7 million cases, with the number of cases having increased by 134.48% since 1990. ². The disease imposes a significant burden through pain, functional limitation, and reduced quality of life, making a scientific understanding of its pathophysiology essential for effective management, particularly within the field of physical therapy.³ This article provides a detailed examination of the relationship between cartilage structure, its response to mechanical loading, and the development of osteoarthritis, establishing a scientific foundation for evidence-based physical rehabilitation interventions.

The scope of this article encompasses the intricate biomechanical and biological systems that govern cartilage health and disease. It begins by detailing the tissue's unique architecture, including the zonal arrangement of collagen fibrils first described by Alfred Benninghoff in 1925, which form arcades that resist both shear and compressive forces ⁴. It further explores the molecular basis of cartilage's compressive stiffness, which is derived from the high osmotic swelling pressure generated by large proteoglycan aggregates, composed of aggrecan monomers bound to a hyaluronan filament ⁵. The article then examines the mechanical principles of cartilage function, such as the biphasic theory proposed by Mow and colleagues, which explains the tissue's time-dependent load-bearing capacity through the frictional drag of interstitial fluid flow ⁶. It also addresses the mechanisms of boundary lubrication provided by the glycoprotein lubricin (PRG4), which minimizes friction at the articular surface ⁷.

Following this foundational overview, the article transitions to the cellular and molecular pathophysiology of OA. It investigates how chondrocytes, the sole cell type in cartilage, sense and respond to mechanical forces through mechanotransduction pathways, such as the activation of the Transient Receptor Potential Vanilloid 4 (TRPV4) ion channel ⁸. Central to the physical therapy perspective is the concept of a 'window' of optimal loading, in which mechanical stimuli maintain tissue homeostasis, while both excessive loading and under-loading can trigger catabolic processes ⁹.¹⁰ The article will detail these catabolic cascades, including the early degradation of aggrecan by aggrecanases like ADAMTS-4 and ADAMTS-5 ¹¹ and the subsequent breakdown of the type II collagen network by enzymes such as Matrix Metalloproteinase-13 (MMP-13) ¹². The role of pro-inflammatory cytokines, including Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α), in promoting this degradative state will be explained ¹³. Finally, the article considers OA as a whole-organ disease, discussing the contributions of subchondral bone remodeling ¹⁴, chondrocyte senescence ¹⁵, and the distinct pathology of post-traumatic OA ¹⁶, all of which inform the application of therapeutic exercise, a core treatment recommended by the 2019 OARSI guidelines ¹⁷.

Composition and architecture of articular cartilage

Articular cartilage is an avascular, aneural, and alymphatic connective tissue that provides a low-friction, load-bearing surface in diarthrodial joints. Its remarkable mechanical properties arise from the specific composition and highly organized architecture of its extracellular matrix.¹⁸ In healthy adults, this matrix is primarily composed of water, which constitutes 65-80% of its total wet weight, along with a solid framework of type II collagen (10-20%) and large proteoglycan aggregates (10-15%) ¹. These components are not uniformly distributed but are arranged into a sophisticated, layered structure that effectively dissipates the complex forces experienced during joint motion.

The solid matrix is dominated by a fibrillar network of type II collagen, which provides the tissue with its shape and significant tensile stiffness. This collagen meshwork entraps the other major solid component: proteoglycans. The principal proteoglycan in cartilage is aggrecan. Multiple aggrecan monomers, each containing numerous negatively charged glycosaminoglycan (GAG) side chains such as chondroitin sulfate and keratan sulfate, bind to a long, central filament of hyaluronan. This binding is stabilized by a specific link protein, forming massive macromolecular aggregates ⁵¹⁹. The high density of negatively charged GAGs imparts a strong Donnan osmotic pressure, attracting a large volume of water into the matrix and creating a substantial swelling pressure. This internal pressure is contained by the tensile forces of the surrounding collagen network and is fundamental to cartilage's ability to resist compressive loads ⁵.

The architectural arrangement of the collagen fibrils was first described in detail by Alfred Benninghoff in 1925 and is often referred to as the Benninghoff arcade model ⁴. This model delineates three primary zones, each with a distinct collagen orientation that corresponds to its specific mechanical function.

1. The Superficial (Tangential) Zone: In this thinnest, outermost layer, the collagen fibrils are densely packed and oriented parallel to the articular surface. This arrangement is ideally suited to withstand the shear, tensile, and compressive forces that occur at the joint interface during movement ⁴²⁰.
2. The Middle (Transitional) Zone: This zone constitutes the largest portion of cartilage thickness. Here, the collagen fibrils are less dense and adopt a more oblique or random orientation, forming an open meshwork. This layer acts as a transition between the distinct architectures of the superficial and deep zones.
3. The Deep (Radial) Zone: In the layer closest to the bone, the collagen fibrils arrange themselves into larger bundles that are oriented perpendicular to the joint surface. These radial fibers anchor the cartilage firmly to the underlying subchondral bone and are optimally positioned to resist compressive forces by transferring loads to the bone ⁴.

Together, these zones form a continuous, arch-like structure. The collagen fibrils originate perpendicularly from the deep zone, curve through the transitional middle zone, and run parallel to the surface in the superficial zone, creating a structure that efficiently distributes both compressive and shear stresses throughout the tissue ⁴. This elegant integration of composition and architecture is essential for the durability and function of healthy articular cartilage.

Biomechanical principles: load bearing and lubrication

The remarkable load-bearing capacity of articular cartilage is not a property of its solid components alone but arises from a sophisticated interaction between its solid matrix and abundant interstitial fluid. This relationship was formally described in the biphasic theory, developed by Van C. Mow and his colleagues at Rensselaer Polytechnic Institute in their 1980 publication ⁶. This model treats cartilage as a composite material comprising two distinct phases: a porous and permeable, yet intrinsically incompressible, solid matrix (the collagen-proteoglycan framework) and a mobile, incompressible fluid phase, which is primarily water ¹⁶. When a compressive load is applied to a joint, the pressure within the interstitial fluid rises almost instantaneously. This fluid pressurization supports the majority of the initial load, effectively shielding the solid matrix from high, potentially damaging, stresses.

The ability to generate and sustain this fluid pressure is critically dependent on the tissue's low permeability, a property governed by the dense proteoglycan network ⁵. Large aggrecan aggregates, formed by monomers binding to a central hyaluronan filament, create a high fixed charge density from their negatively charged glycosaminoglycan side chains ⁵. This concentration of charge generates a powerful osmotic swelling pressure that resists fluid exudation and contributes significantly to the tissue's compressive stiffness. Under sustained loading, fluid is slowly forced out of the matrix. As described by Mow et al., the resistance encountered by the fluid as it flows through the dense, porous solid matrix creates frictional drag, which is the principal mechanism for energy dissipation and is responsible for the tissue’s characteristic time-dependent, or viscoelastic, response to load ⁶.

In addition to withstanding compression, cartilage must provide a nearly frictionless surface for smooth joint articulation. This is accomplished through a combination of lubrication mechanisms. During dynamic loading and movement, the exuded interstitial fluid can form a thin layer, known as fluid-film lubrication, that physically separates the articulating surfaces. Under conditions of slow movement or high static load, however, this fluid film can be squeezed out. In these situations, boundary lubrication becomes the dominant and essential mechanism. This function is performed by a specialized glycoprotein named lubricin, also known as Proteoglycan 4 (PRG4) ⁷. A 2005 study by Rhee and colleagues demonstrated that lubricin molecules, secreted by superficial zone chondrocytes, adsorb to the cartilage surfaces ⁷. They form a dense, hydrated, brush-like layer that prevents direct contact between the asperities of the opposing cartilage surfaces, maintaining an extremely low coefficient of friction even under high pressure.

The integrity of both the biphasic load-bearing system and the lubricin-mediated boundary lubrication is essential for joint health. In the early stages of osteoarthritis, enzymatic degradation leads to a loss of proteoglycans, which reduces the tissue's fixed charge density ²¹. As described by Bank et al., this loss increases cartilage permeability, allowing fluid to escape more readily under load and diminishing the tissue's ability to maintain fluid pressurization ²¹. Consequently, a greater proportion of the compressive load is transferred directly to the solid collagen framework, increasing tissue stress, accelerating mechanical wear, and reducing the tissue's overall compressive stiffness, known as the aggregate modulus ²¹.

Cellular mechanobiology: how chondrocytes sense and respond to load

Chondrocytes, the sole cell type residing within the avascular and aneural articular cartilage matrix, are responsible for tissue maintenance and repair. These cells function as sophisticated mechanosensors, translating physical forces into biochemical signals through a process known as mechanotransduction. This cellular activity is fundamental to maintaining tissue homeostasis, operating within a proposed 'window' of optimal loading, a concept formalized by a research group including Thomas Andriacchi and R. Lane Smith in 2004 ⁹²². According to this framework, a specific range of dynamic compressive loading stimulates chondrocytes to maintain a healthy balance between matrix synthesis (anabolism) and degradation (catabolism). Both mechanical under-loading, as seen in prolonged immobilization, and overloading, resulting from acute trauma or chronic joint instability, disrupt this equilibrium and promote a net catabolic state leading to tissue degeneration ⁹.

The process by which chondrocytes sense mechanical strain begins with the deformation of the cell and its immediate pericellular matrix. This physical distortion is converted into intracellular signals by several mechanisms, including integrin-mediated attachments to the extracellular matrix and dedicated mechanosensitive ion channels. A key discovery in this area was the identification of the Transient Receptor Potential Vanilloid 4 (TRPV4) ion channel as a primary molecular mechanosensor in chondrocytes ⁸. Work by O'Conor, Leddy, and colleagues demonstrated that activation of the TRPV4 channel by mechanical or osmotic stress triggers an influx of extracellular calcium ions (Ca2+) ⁸²³. This resulting transient increase in intracellular calcium concentration serves as a critical secondary messenger, initiating downstream signaling cascades that modulate gene expression and cellular behavior.

When mechanical stimuli fall within the physiological window, these calcium signals, along with other pathways, promote an anabolic response. Chondrocytes increase the synthesis and assembly of essential matrix components, including type II collagen and large aggregating proteoglycans like aggrecan, to repair and replace molecules lost through normal turnover ⁸. This homeostatic activity preserves the tissue's unique biphasic and viscoelastic properties.

Conversely, mechanical loads that are either insufficient or excessive in magnitude or frequency push the chondrocyte toward a catabolic phenotype. Injurious overloading can directly induce chondrocyte apoptosis or trigger a stress response that includes the production of pro-inflammatory cytokines like Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α) ¹³. These molecules, in turn, stimulate the chondrocytes to upregulate the expression of matrix-degrading enzymes. Key among these are the aggrecanases ADAMTS-4 and ADAMTS-5, which cleave the core protein of aggrecan ¹¹, and Matrix Metalloproteinase-13 (MMP-13), the principal collagenase responsible for degrading the type II collagen framework in osteoarthritic cartilage ¹². The failure of chondrocytes to maintain an anabolic/catabolic balance in an altered mechanical environment is therefore a central event in the pathogenesis of osteoarthritis.

Pathophysiology of osteoarthritis: the breakdown cascade

The shift toward a catabolic state precipitates a well-defined sequence of destructive events within the articular cartilage matrix. The initial pathological changes are primarily biochemical and biomechanical, beginning long before structural damage is visible. A key early event is the loss of aggrecan from the extracellular matrix. This depletion reduces the matrix's fixed charge density, disrupting the osmotic balance that enables cartilage to resist compression. Consequently, the tissue's water content increases, as does its permeability, a state described in a 2000 study by Bank and colleagues ²¹. This hydration change paradoxically weakens the tissue, leading to a measurable decrease in its compressive stiffness (aggregate modulus) and making it substantially more susceptible to mechanical damage from joint loading ²¹.

This compromised matrix becomes the target of specific enzymatic degradation. The catabolic cascade is largely driven by two classes of enzymes produced by the chondrocytes themselves. The first to act are typically the aggrecanases, particularly A Disintegrin and Metalloproteinase with Thrombospondin Motifs 4 and 5 (ADAMTS-4 and ADAMTS-5) ¹¹. These enzymes are identified as the principal agents responsible for cleaving aggrecan monomers from their hyaluronan backbone in the early phases of osteoarthritis ²⁴. This enzymatic action accelerates the loss of proteoglycans, further degrading the tissue's compressive properties and exposing the underlying collagen framework.

Once the protective proteoglycan shield is depleted, the type II collagen network, which provides the cartilage with its form and tensile strength, becomes vulnerable. The primary enzyme responsible for its destruction is Matrix Metalloproteinase-13 (MMP-13), a collagenase with a high specificity for type II collagen ¹². Research by Mitchell et al. in 1996 first identified MMP-13 as the critical collagenolytic enzyme in osteoarthritic cartilage ¹². Its activity severs the collagen fibrils, leading to the irreversible loss of tissue integrity, fibrillation, and the eventual full-thickness erosion characteristic of advanced OA ²⁵.

This entire breakdown cascade can be initiated by a single traumatic event, leading to post-traumatic osteoarthritis (PTOA). Studies using animal models, such as work by Ewers and Haut published in 2000, have demonstrated that a single injurious impact to a joint is sufficient to trigger the pathological process ¹⁶. Such an impact can cause immediate and widespread chondrocyte apoptosis, microscopic damage to the matrix, and a powerful inflammatory response. This acute insult initiates the same chronic, progressive enzymatic degradation by aggrecanases and MMPs that characterizes idiopathic OA, creating a direct pathway from mechanical injury to long-term joint failure ¹⁶. For the physical therapist, understanding this cascade from initial biochemical shift to final structural failure is fundamental to designing interventions aimed at managing loads and mitigating disease progression.

The 'whole-organ' and systemic nature of osteoarthritis

The traditional view of osteoarthritis (OA) as a disease of simple cartilage "wear and tear" has been superseded by a model that recognizes it as the failure of the joint as a 'whole organ'. This paradigm shift incorporates the active and interconnected pathologies of tissues beyond the articular surface, particularly the subchondral bone ¹⁴. Research by David Burr and Matthew Gallant has established that subchondral bone remodeling is not merely a reaction to cartilage loss but a primary contributor to the disease process ¹⁴³. Pathological changes, including stiffening of the subchondral plate and the development of bone marrow lesions visible on magnetic resonance imaging (MRI), alter the mechanical environment of the overlying cartilage ¹⁴. This altered bone structure can fail to adequately attenuate joint loads, transmitting excessive stress to the chondrocytes and disrupting the normal crosstalk between the bone and cartilage compartments, thereby accelerating cartilage degradation.

Concurrent with these structural changes is a persistent, low-grade inflammatory state within the joint, often termed synovitis. The pro-inflammatory cytokines Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α) are central mediators in this process ¹³. As detailed by Mary Goldring and Miguel Otero in 2011, these signaling molecules bind to receptors on chondrocytes, triggering intracellular cascades that promote a catabolic phenotype ¹³. This cellular response involves the upregulation and production of matrix-degrading enzymes, such as Matrix Metalloproteinases (MMPs) and aggrecanases. Simultaneously, IL-1β and TNF-α actively suppress the anabolic functions of the chondrocyte, inhibiting the synthesis of essential matrix components like type II collagen and aggrecan. This dual action creates a destructive imbalance, where matrix degradation systematically outpaces repair, leading to the progressive structural failure of the cartilage ¹³.

The age-related progression of OA is also strongly linked to the phenomenon of cellular senescence in chondrocytes. With age and cumulative stress, chondrocytes can enter a state of irreversible growth arrest while remaining metabolically active ¹⁵. A 2005 study by Yudoh and colleagues identified that these senescent chondrocytes, which accumulate in osteoarthritic cartilage, express markers such as p16INK4a ¹⁵. Instead of contributing to matrix maintenance, these cells adopt a senescence-associated secretory phenotype (SASP), releasing a cocktail of pro-inflammatory cytokines, chemokines, and matrix-degrading enzymes into the local environment. This secretion perpetuates the low-grade inflammation ('inflammaging') and directly contributes to tissue breakdown ¹⁵. Further research has demonstrated that this senescence program is not just a passive consequence of aging; it can be actively induced by the same pro-inflammatory cytokines implicated in OA. The NF-κB signaling pathway, a key target of IL-1β and TNF-α, has been shown to drive chondrocytes into a p16INK4a-dependent senescent state, creating a damaging feedback loop between inflammation and cellular aging. This multifactorial view, integrating bone pathology, cytokine activity, and cellular senescence, frames OA as a complex organ-system failure, guiding a more holistic therapeutic approach.

Clinical relevance and therapeutic implications in physical therapy

The scientific understanding of cartilage structure and pathophysiology provides the direct rationale for physical therapy as a primary, evidence-based intervention for osteoarthritis (OA). With knee OA alone affecting over 300 million people and ranking as a leading global cause of disability ², effective management strategies are a clinical priority. Major international clinical practice guidelines, such as the 2019 recommendations from the Osteoarthritis Research Society International (OARSI), strongly endorse therapeutic exercise as a core, first-line treatment for individuals with knee OA ¹⁷. The justification for this recommendation moves beyond simple muscle strengthening and is rooted in the biological effects of mechanical loading on chondrocyte function and the articular environment.

The central principle guiding therapeutic exercise is the concept of a 'window' of optimal mechanical loading, as proposed in a 2004 framework by Andriacchi and colleagues ⁹²². This model posits that both disuse (under-loading) and excessive or injurious loading (over-loading) promote a catabolic state, leading to cartilage degradation. In contrast, mechanical stimuli applied within a specific homeostatic range can promote an anabolic, or matrix-building, response. Physical therapists design exercise programs to apply controlled, cyclic loads that fall within this theoretical anabolic window. The goal is to stimulate chondrocytes to synthesize new matrix components, such as type II collagen and aggrecan, without inducing the inflammatory and enzymatic damage associated with overload ⁹.

The mechanisms for this therapeutic effect operate at the cellular and molecular levels. During a prescribed exercise like cycling or walking, the cyclic compression and release of cartilage drives the flow of interstitial fluid, a key component of the tissue's biphasic load-bearing behavior described by Mow et al. ⁶. This fluid movement is critical not only for transporting nutrients to the avascular chondrocytes but also for generating mechanotransductive signals. Chondrocytes sense these mechanical and osmotic changes through specialized membrane proteins, such as the Transient Receptor Potential Vanilloid 4 (TRPV4) ion channel ⁸. Activation of TRPV4 translates the physical forces of exercise into intracellular calcium signals, which in turn can upregulate the synthesis of matrix proteins ⁸²³.

Furthermore, therapeutic loading may counteract the catabolic cascade that defines OA. The osteoarthritic joint is characterized by a pro-inflammatory environment, where cytokines like IL-1β and TNF-α stimulate chondrocytes to produce matrix-degrading enzymes ¹³. These enzymes include the aggrecanases ADAMTS-4 and ADAMTS-5, which break down proteoglycans ¹¹, and Matrix Metalloproteinase-13 (MMP-13), the primary collagenase that degrades the collagen network ¹². By providing a regular, non-injurious mechanical stimulus, therapeutic exercise may help modulate these inflammatory pathways and shift the cellular balance away from catabolism and towards matrix homeostasis. Therefore, the prescription of exercise in physical rehabilitation is not merely for functional improvement but is a targeted biological intervention, consistent with principles of evidence-based practice outlined in foundational physical therapy texts.

Current research, controversies, and future directions

The clinical and societal significance of osteoarthritis (OA) is substantial, underscoring the urgency for improved interventions. The 2017 Global Burden of Disease study identified knee OA as the 11th leading cause of disability worldwide, with an estimated prevalence of 303.1 million people ². While therapeutic exercise is a cornerstone of management recommended by organizations like OARSI ¹⁷, a central controversy in physical therapy and biomechanics involves defining the precise parameters of beneficial mechanical loading. A 2004 framework proposed by Andriacchi and colleagues introduced the concept of a 'window' of optimal loading, hypothesizing that cartilage homeostasis is maintained only within a specific range of mechanical stimuli ⁹. According to this model, both disuse (under-loading) and excessive or injurious forces (over-loading) trigger catabolic pathways that lead to tissue degradation. The challenge for current research is to quantify this therapeutic window in terms of load magnitude, frequency, and duration for different patient populations, a task critical to refining exercise prescription and advancing the professional practice of physical therapy.

Future research is increasingly focused on moving beyond symptom management toward developing true disease-modifying osteoarthritis drugs (DMOADs) and other biological interventions. One major avenue involves creating specific inhibitors for the key enzymes responsible for matrix breakdown. Efforts are ongoing to develop drugs that can selectively block the activity of aggrecanases like ADAMTS-5 ¹¹ or the primary collagen-degrading enzyme, MMP-13 ¹². Another innovative strategy aims to pharmacologically replicate the positive effects of mechanical loading. Research has identified specific molecular mechanosensors, such as the Transient Receptor Potential Vanilloid 4 (TRPV4) ion channel, which translates mechanical forces into anabolic intracellular signals in chondrocytes ⁸. The development of agonists for these pathways could potentially stimulate cartilage matrix synthesis without requiring physical loading, offering a therapeutic option for patients unable to exercise.

The scope of investigation has also expanded to include cellular aging and the role of adjacent tissues. The concept of chondrocyte senescence, an age-related state where cells cease to divide and instead secrete a cocktail of inflammatory and catabolic factors, is now recognized as a contributor to the low-grade inflammation in OA ¹⁵. This has opened a new therapeutic frontier exploring 'senolytics', drugs designed to selectively clear these dysfunctional senescent cells from the joint. Furthermore, the view of OA has evolved from a 'cartilage-only' disease to a 'whole-organ' failure. Research into subchondral bone remodeling highlights how changes in the bone beneath the cartilage, such as the formation of bone marrow lesions, actively contribute to cartilage breakdown and disease progression ¹⁴. This holistic perspective suggests that effective future treatments may need to target multiple tissues, including both bone and cartilage, or intervene acutely after injury to prevent the cascade of events that leads to post-traumatic OA ¹⁶.

Sources

1. Mow VC, Ratcliffe A, Poole AR., Biomaterials (1992) - https://www.sciencedirect.com/science/article/abs/pii/014296129290008L

2. Li, H. et al. (2024) - https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0304315

3. Howard A. Rusk, Rehabilitation medicine (1964) - https://openlibrary.org/works/OL6912991W

4. Benninghoff, A., Zeitschrift für Zellforschung und Mikroskopische Anatomie (1925) - https://link.springer.com/article/10.1007/BF02455423

5. Mankin HJ, Mow VC, Buckwalter JA, Iannotti JP, Ratcliffe A. Articular cartilage structure, composition, and function. In: Simon SR, ed. Orthopaedic Basic Science. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1994:1-44 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779598/

6. Mow VC, Kuei SC, Lai WM, Armstrong CG., Journal of Biomechanical Engineering (1980) - https://asmedigitalcollection.asme.org/biomechanical/article-abstract/102/1/73/472691/Biphasic-Creep-and-Stress-Relaxation-of-Articular

7. Rhee DK, Pirog M, Zappone B, et al., The Journal of Clinical Investigation (2005) - https://www.jci.org/articles/view/25393

8. O'Conor SK, Leddy HA, Benefield HC, et al., FASEB Journal (2014) - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929655/

9. Andriacchi TR, Mündermann A, Smith RL, et al., Annals of Biomedical Engineering (2004) - https://pubmed.ncbi.nlm.nih.gov/15160913/

10. Mark Dutton, McGraw-Hills NPTE (National Physical Therapy Exam) (2012) - https://openlibrary.org/works/OL16343145W

11. Verma P, Dalal K., Journal of Cellular Biochemistry (2011) - https://pubmed.ncbi.nlm.nih.gov/21815191/

12. Mitchell PG, Magna HA, Reeves LM, et al., The Journal of Clinical Investigation (1996) - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC507119/

13. Goldring MB, Otero M., Current Opinion in Rheumatology (2011) - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398416/

14. Burr DB, Gallant MA., Bone (2012) - https://pubmed.ncbi.nlm.nih.gov/22542696/

15. Loeser RF, 2009 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818252/

16. Ewers BJ, Haut RC., Journal of Orthopaedic Research (2000) - https://onlinelibrary.wiley.com/doi/abs/10.1002/1554-527X(200009)18:5%3C756::AID-JOR11%3E3.0.CO;2-M

17. Bannuru RR, Osani MC, Vaysbrot EE, et al., Osteoarthritis and Cartilage (2019) - https://www.oarsijournal.com/article/S1063-4584(19)31154-0/fulltext

18. John E. Hall, Guyton and Hall Textbook of Medical Physiology (Guyton Physiology) (2015) - https://openlibrary.org/works/OL22472185W

19. Li Y, et al., The role of matrix metalloproteinase-13 in the pathogenesis of osteoarthritis. International Journal of Molecular Sciences (2021) - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912089/

20. Verma P, Dalal K., ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. Journal of Cellular Biochemistry (2011) - https://onlinelibrary.wiley.com/doi/10.1002/jcb.23298

21. Bank RA, Soudry M, Mizrahi J, et al., Osteoarthritis and Cartilage (2000) - https://pubmed.ncbi.nlm.nih.gov/10969032/

22. Burr DB, Gallant MA., Bone remodelling in osteoarthritis. Current Opinion in Rheumatology (2012) - https://journals.lww.com/co-rheumatology/abstract/2012/09000/bone_remodelling_in_osteoarthritis.8.aspx

23. Philipot D, et al., The p16INK4a-dependent senescence of human articular chondrocytes is reversible and is driven by the pro-inflammatory cytokine-induced NF-κB pathway. Arthritis Research & Therapy (2014) - https://arthritis-research.biomedcentral.com/articles/10.1186/ar4494

24. Bank RA, et al., The role of collagens, proteoglycans and their interactions in the mechanical properties of articular cartilage. Journal of Anatomy (2000) - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1468126/

25. Physical Rehabilitation: Evidence-based Examination, Evaluation, and Intervention by Michelle H. Cameron, Linda G. Monroe (2007, Saunders) - https://books.google.com/books/about/Physical_Rehabilitation.html?hl=&id=r7xaAAAAYAAJ